Cady Lapoint, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1550 W Spicerville Hwy, Charlotte, MI 48813 Phone: 517-231-1593 |
Mr. David G Vandebunte, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 616 Meijer St, Charlotte, MI 48813 Phone: 517-541-5935 |
Ms. Cynthia Anne Hutchinson, PA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 1033 Healthcare Dr, Charlotte, MI 48813 Phone: 517-541-2673 |
Emma K Sharp, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 616 Meijer Dr # 101, Charlotte, MI 48813 Phone: 517-543-7976 |
Ms. Kimberly Marie Comeau, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 616 Meijer Dr, Charlotte, MI 48813 Phone: 517-541-5935 |
News Archive
The amount of food needed to feed the world's population in the future is of vital importance. To date, scientists have only considered this question from the perspective of how much food people can afford to buy, how much food is healthy or what can be sustainably produced.
A recent article by Kessler Foundation researchers underscores the importance of processing speed in overall cognitive function in individuals with multiple sclerosis and their performance of everyday life activities.
QIAGEN N.V. has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in Ipsogen S.A. and subsequently make a public offer to fully acquire a global leader in molecular profiling and personalized healthcare diagnostics for a broad range of hematological cancers.
Metabolon, Inc., the leader in metabolomics, biomarker discovery and analysis, announces the publication of "Novel Role of Adenosine Signaling in Sickle Cell Disease", in Nature Medicine. Application of non-targeted biochemical profiling (metabolomics) to a mouse model of sickle cell disease (SCD) revealed a detrimental role of adenosine signaling in SCD and suggested novel therapeutic targets. The study was carried out in collaboration with The University of Texas Health Science Center at Houston.
The trial of a new drug for rheumatoid arthritis (RA) has revealed that an injection once a month could stop the disease progressing.
› Verified 6 days ago